NCT05233293 2023-08-15
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Unknown
Clinical Trials
11 trialsNCT02821754 2023-03-28
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05028439 2023-02-21
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT04301999 2021-09-01
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
First People's Hospital of Hangzhou
Phase NA Completed
NCT01844245 2020-10-14
Endobiliary RFA for Unresectable Malignant Biliary Strictures
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT02592538 2019-11-19
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT02646514 2019-01-28
Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study
Yonsei University
Phase NA Unknown
NCT02482454 2017-08-01
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
The First People's Hospital of Changzhou
Phase 2/3 Active not recruiting
NCT03166436 2017-05-30
RFA for Malignant Biliary Obstruction
Institute for Clinical and Experimental Medicine
Phase NA Unknown
NCT02468076 2016-05-11
IGNITE-1
Universitaire Ziekenhuizen KU Leuven
Phase 2 Completed
NCT02582541 2015-10-21
Endoscopic Biliary RFA of Malignant Bile Duct Obstruction
The Second Hospital of Nanjing Medical University
Phase NA Unknown